Merck KGaA (MEX:MRK1N) Cyclically Adjusted FCF per Share: MXN162.85 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MRK1N Merck KGaA MEX:MRK1N
88 GF Score
Price MXN3,299.85
GF Value MXN3,360.43
! 10 Warning Signs
View Full Analysis

What is Merck KGaA Cyclically Adjusted FCF per Share?

Merck KGaA MEX:MRK1N 88 Cyclically Adjusted FCF per Share is MXN162.85 as of Mar. 2026. GuruFocus rates MEX:MRK1N with a GF Score™ of 88/100 and a GF Value™ of MXN3,360.43. The stock has 10 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Merck KGaA's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN13.079. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN162.85 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Merck KGaA's average Cyclically Adjusted FCF Growth Rate was 4.10% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 1.90% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 5.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Merck KGaA was 9.50% per year. The lowest was 1.90% per year. And the median was 6.55% per year.

As of today (2026-08-13), Merck KGaA's current stock price is MXN3299.85. Merck KGaA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN162.85. Merck KGaA's Cyclically Adjusted Price-to-FCF of today is 20.26.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Merck KGaA was 52.13. The lowest was 19.89. And the median was 28.95.


Merck KGaA  (MEX:MRK1N) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Merck KGaA's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=3299.85/162.85
=20.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Merck KGaA was 52.13. The lowest was 19.89. And the median was 28.95.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Merck KGaA Cyclically Adjusted FCF per Share Related Terms


Merck KGaA Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Merck KGaA's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck KGaA Cyclically Adjusted FCF per Share Chart

Merck KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 108.29 91.91 117.48 120.77 140.77

Merck KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 132.93 152.69 156.17 140.77 162.85

MEX:MRK1N vs ZTS, UTHR, VTRS: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Merck KGaA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck KGaA Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck KGaA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Merck KGaA's Cyclically Adjusted Price-to-FCF falls into.


MEX:MRK1N
88GF Score
Merck KGaA MEX:MRK1N
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merck KGaA Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck KGaA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=13.079/131.2583*131.2583
=13.079

Current CPI (Mar. 2026) = 131.2583.

Merck KGaA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 7.337 100.717 9.562
201609 42.830 101.017 55.652
201612 23.898 101.217 30.991
201703 16.957 101.417 21.947
201706 12.475 102.117 16.035
201709 25.998 102.717 33.222
201712 12.138 102.617 15.526
201803 6.713 102.917 8.562
201806 8.741 104.017 11.030
201809 25.086 104.718 31.444
201812 20.938 104.217 26.371
201903 13.714 104.217 17.272
201906 24.711 105.718 30.681
201909 35.455 106.018 43.896
201912 17.088 105.818 21.196
202003 9.367 105.718 11.630
202006 15.185 106.618 18.694
202009 53.698 105.818 66.608
202012 33.488 105.518 41.657
202103 47.851 107.518 58.417
202106 33.704 108.486 40.779
202109 52.792 109.435 63.320
202112 41.579 110.384 49.442
202203 17.215 113.968 19.827
202206 26.756 115.760 30.338
202209 49.175 118.818 54.324
202212 22.981 119.345 25.275
202303 8.962 122.402 9.610
202306 12.603 123.140 13.434
202309 33.912 124.195 35.841
202312 19.981 123.773 21.189
202403 10.980 125.038 11.526
202406 23.132 125.882 24.120
202409 45.421 126.198 47.242
202412 36.334 127.041 37.540
202503 1.627 127.779 1.671
202506 6.144 128.412 6.280
202509 52.227 129.255 53.036
202512 37.101 129.361 37.645
202603 13.079 131.258 13.079

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN162.85 mean?
Merck KGaA (MEX:MRK1N) has a Cyclically Adjusted FCF per Share of MXN162.85 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Merck KGaA and its competitors.
Is Merck KGaA's Cyclically Adjusted FCF per Share too high?
Merck KGaA's current Cyclically Adjusted FCF per Share is MXN162.85. Overall, Merck KGaA has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Merck KGaA's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Merck KGaA's Cyclically Adjusted FCF per Share of MXN162.85 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Merck KGaA and its competitors. Merck KGaA's current Cyclically Adjusted FCF per Share is MXN162.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merck KGaA stock overvalued right now?
Merck KGaA (MEX:MRK1N) has a current Cyclically Adjusted FCF per Share of MXN162.85. The stock's GF Value™ is MXN3,360.43, compared to a current price of MXN3,299.85 — trading 1.8% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN162.85. Merck KGaA's overall GF Score™ is 88/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Merck KGaA (MEX:MRK1N), the current Cyclically Adjusted FCF per Share is MXN162.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merck KGaA (MEX:MRK1N) Overvalued in 2026?

Based on GuruFocus' analysis, Merck KGaA stock appears to be undervalued. The current stock price of MXN3,299.85 is trading 1.8% below its estimated GF Value™ of MXN3,360.43.

Key valuation signals for MEX:MRK1N:

  • Cyclically Adjusted FCF per Share: MXN162.85
  • GF Value™: MXN3,360.43 vs. price of MXN3,299.85 (1.8% below fair value)
  • GF Score™: 88/100 with 10 warning signs

No single metric tells the full story. See the MEX:MRK1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck KGaA Business Description

Address Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.
88GF Score

Get the complete analysis for MEX:MRK1N

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,299.85
Price
MXN3,360.43
GF Value